MUMTAZ MOHIDIN
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism BABYLON, NY NPI 1689625253
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism NY Novo Nordisk AS All categories
General Payments — all program years on this page
$2,815.99
- Category: General Payments
- Program years: PY2018–2021
- Record count: 164
- As of (CMS publication): 2026-01-23
Latest program year (PY2021): $130.90 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2021) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $130.90 | 6 |
By paying entity
Latest program year (PY2021) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $42.64 | 2 |
| Lilly USA, LLC | $32.11 | 1 |
| Corcept Therapeutics | $25.27 | 1 |
| Amneal Pharmaceuticals LLC | $15.55 | 1 |
| ABBVIE INC. | $15.33 | 1 |
By program year
Records — PY2021 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 795731807 | AbbVie Inc. | $15.33 | 04/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 811338643 | Novo Nordisk Inc | $22.87 | 04/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 811629627 | Novo Nordisk Inc | $19.77 | 04/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 818592851 | Lilly USA, LLC | $32.11 | 05/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 829669855 | Amneal Pharmaceuticals LLC | $15.55 | 05/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 837533233 | Corcept Therapeutics | $25.27 | 05/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.